Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma

May 2, 2018

Hetero Labs divulges betulinic acid analogues for HIV infection

May 2, 2018

Lactobacillus reuteri may reduce bone loss in older women

May 2, 2018

Genocea files IND for phase I/IIa study of GEN-009

May 2, 2018

DKFZ patents novel KLK6 inhibitors

May 2, 2018

FDA approves Kymriah for relapsed or refractory large B-cell lymphoma

May 2, 2018

Spark Therapeutics sells priority review voucher to Jazz Pharmaceuticals

May 2, 2018

AbbVie submits European MAA for risankizumab in moderate to severe plaque psoriasis

May 2, 2018

FDA grants QIDP and fast track designations to oral SCY-078 for vulvovaginal candidiasis

May 2, 2018

Symphogen initiates first-in-human study of Sym-022 in advanced solid tumors or lymphomas

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...